Predicting malignancy in patients with adrenal tumors using (18)F-FDG-PET/CT SUVmax

BACKGROUND AND OBJECTIVES: (18)F-FDG-PET/CT parameters may help distinguish malignant from benign adrenal tumors, but few have been externally validated or determined based on definitive pathological confirmation. We determined and validated a threshold for (18)F-FDG-PET/CT maximum standard uptake v...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:J Surg Oncol
Päätekijät: Vos, Elvira L., Grewal, Ravinder K., Russo, Ashley E., Reidy-Lagunes, Diane, Untch, Brian R., Gavane, Somali C., Boucai, Laura, Geer, Eliza, Gopalan, Anuradha, Chou, Joanne F., Capanu, Marinela, Strong, Vivian E.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2020
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7793554/
https://ncbi.nlm.nih.gov/pubmed/32914407
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jso.26203
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia